English
This article is from Indian Journal of Sexually Transmitted Diseases , volume 31 . Abstract Background:: Tenofovir (TDF) is preferred nucleoside reverse transcriptase inhibitors (NRTI) for the treatment of human immunodeficiency virus infection because of its potency and safety. Renal toxicity with TDF use is low and comparable with other NRTI in clinical trials, but there are many case studies and small case series of renal dysfunction with TDF. Materials and Methods:: This is an observational longitudinal cohort of patients started on a TDF-based regimen from January 2007 to April 2010. Patients were evaluated at baseline and with every follow-up visit for serum creatinine and calculated creatinine clearance (Cockroft-Gault formula). In addition to this, the patients were also subjected to test for serum potassium, phosphorous and urine examinations as and when indicated. Renal dysfunction was defined as rise in serum creatinine to more than the upper level of normal (>1.2 mg%). Results:: Of 1,271 patients started on a TDF-containing antiretroviral treatment (ART) 83 (6.53%) developed renal dysfunction, of which 79 had impaired serum creatinine and five had Fanconi’s syndrome. Re
Sign in with your free account to read, download EPUBs or listen.
Ebook · Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India. · Patel, Ketan K., Patel, Atul K., Ranjan, Rajiv R., Patel, Apurva R., Patel, Jagdish K. · Internet Archive